Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
10000 participants
OBSERVATIONAL
2021-03-01
2026-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Subjects with a genetic disease
No intervention
No intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
No intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The participant is 2 months or older
* The participant is diagnosed with a genetic disease
* The participant is a first degree relative of a subject diagnosed with a genetic disease
Exclusion Criteria
* The participant is younger than 2 months
* The participant is not diagnosed with a genetic disease
* The participant is not a first degree relative of a subject diagnosed with a genetic disease
2 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Arcensus GmbH
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Center Mother Teresa
Tirana, , Albania
The Children's hospital & Institute of child health
Lahore, Punjab Province, Pakistan
Pakistan Institute of Medical Sciences (PIMS)
Islamabad, , Pakistan
Children's Hospital & The Institute of Child Health
Multan, , Pakistan
Khyber institute of Child Health and Children Hospital (KICH)
Peshawar, , Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Paskal Cullufi, Prof.
Role: primary
Huma Cheema, Prof.
Role: primary
Maqbool Hussain, Prof.
Role: primary
Nuzhat Rana, Prof.
Role: primary
Khalil Rehman, Dr.
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MetaPrint-2021
Identifier Type: -
Identifier Source: org_study_id